- Report
- October 2025
- 81 Pages
From €3070EUR$3,450USD£2,702GBP
-
Journal - October 2025
Global
- Report
- May 2025
- 31 Pages
China
From €1072EUR$1,205USD£944GBP
- Report
- October 2024
- 106 Pages
Global
From €885EUR$995USD£779GBP
- Report
- September 2024
- 115 Pages
Global
From €4004EUR$4,500USD£3,525GBP
- Report
- September 2024
- 117 Pages
Global
From €4004EUR$4,500USD£3,525GBP
- Report
- July 2024
- 110 Pages
Global
From €2625EUR$2,950USD£2,311GBP
- Report
- July 2024
- 97 Pages
North America
From €2625EUR$2,950USD£2,311GBP
- Report
- July 2024
- 112 Pages
Europe
From €3070EUR$3,450USD£2,702GBP
- Report
- July 2024
- 89 Pages
Africa, Middle East
From €2625EUR$2,950USD£2,311GBP
- Report
- July 2024
- 89 Pages
From €2625EUR$2,950USD£2,311GBP
- Report
- July 2024
- 105 Pages
Asia Pacific
From €3070EUR$3,450USD£2,702GBP
- Report
- May 2024
- 257 Pages
Global
From €4405EUR$4,950USD£3,877GBP
From €2002EUR$2,250USD£1,762GBP
- Report
- May 2024
- 97 Pages
From €2625EUR$2,950USD£2,311GBP
- Report
- May 2024
- 105 Pages
North America
From €2625EUR$2,950USD£2,311GBP
- Report
- May 2024
- 97 Pages
Africa, Middle East
From €2625EUR$2,950USD£2,311GBP
- Report
- May 2024
- 128 Pages
Global
From €2625EUR$2,950USD£2,311GBP
- Report
- May 2024
- 122 Pages
Europe
From €3070EUR$3,450USD£2,702GBP
- Report
- May 2024
- 118 Pages
Asia Pacific
From €3070EUR$3,450USD£2,702GBP

Biomedicine is a branch of biotechnology that focuses on the development of medical treatments and products. It involves the use of living organisms, such as bacteria, viruses, and cells, to create treatments and products that can be used to diagnose, prevent, and treat diseases. Biomedicine also includes the development of medical devices, such as prosthetics, and the use of genetic engineering to create new treatments.
Biomedicine is a rapidly growing field, with many companies investing in research and development. Companies in the biomedicine market are focused on developing treatments and products for a variety of diseases, including cancer, diabetes, and cardiovascular diseases. They are also working to develop treatments for rare diseases and to improve existing treatments.
Some of the companies in the biomedicine market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Celgene, Gilead Sciences, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. Show Less Read more